TKT and breast neoplasm: As regards A3A, the majority of breast tumors have ≤72.7% APOBEC3 signature mutations in YTCW motifs, which is the overall preference of A3A here in the HAP1-TK-M9 system suggesting the involvement of at least one other A3 enzyme.